Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Fen

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Oncogene|July 29, 2022
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 7, 2022
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaFeng-Kun Zhang, Qian-Zhi Ni, Kang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axisHao Jiang, Hui-Jun Cao, Ning Ma, et al.
Nature Communications|May 25, 2021
PPDPF alleviates hepatic steatosis through inhibition of mTOR signalingNing Ma, Yi-Kang Wang, Sheng Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1Qian-Zhi Ni, Bing Zhu, Yan Ji, et al.
Metabolism: Clinical and Experimental|September 13, 2024
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensusXu-Fen Zeng, Krista A Varady, Xiang-Dong Wang, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Oncogene|July 29, 2022
PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3Qian-Wen Zheng, Qian-Zhi Ni, Bing Zhu, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 7, 2022
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular CarcinomaFeng-Kun Zhang, Qian-Zhi Ni, Kang Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2020
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axisHao Jiang, Hui-Jun Cao, Ning Ma, et al.
Nature Communications|May 25, 2021
PPDPF alleviates hepatic steatosis through inhibition of mTOR signalingNing Ma, Yi-Kang Wang, Sheng Xu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 1, 2022
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1Qian-Zhi Ni, Bing Zhu, Yan Ji, et al.
Metabolism: Clinical and Experimental|September 13, 2024
The role of dietary modification in the prevention and management of metabolic dysfunction-associated fatty liver disease: An international multidisciplinary expert consensusXu-Fen Zeng, Krista A Varady, Xiang-Dong Wang, et al.
Pageof 7